JAKAVI ruxolitinib (as phosphate) 10 mg tablet blister pack

Approval Id: 9655d1587382ccf3
Product Name: JAKAVI ruxolitinib (as phosphate) 10 mg tablet blister pack
Artg Id: 232702
Artg Name: JAKAVI ruxolitinib (as phosphate) 10 mg tablet blister pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2015-12-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-CMI-01925-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-PI-01918-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

9655d1587382ccf3

Type

Standard